LifeSci Venture Partners

About The Fund

Founded in 2017, LifeSci Venture Partners is a corporate venture capital arm of LifeSci Partners, specializing in investments in the biotech and health sectors. Based in New York, they focus on leveraging in-depth scientific research to support companies through their stages of development, including company building, private financing, and transition to public markets. LifeSci Venture Partners implements a rigorous due diligence process and utilizes a unique support system for their portfolio companies through the global LifeSci Partners network. This network includes advisory, investor relations, public relations, executive recruiting, investment banking, and strategic partnership services. With a commitment to reshaping medical care and the healthcare system through novel approaches to molecular medicine, technology, or healthcare delivery, they collaborate with visionary management teams, typically investing in mid-to-late-stage ventures that have achieved proof of concept and are nearing a public market transition within 24 months. They support high growth companies with flexible capital structures and friendly terms, leveraging scientific and financial expertise to be a long-term, high-conviction investor. Their investment approach focuses on transformational business models, proving collaborative capital that can accelerate medical breakthroughs. They also highlight successful partnerships with portfolio companies such as Engage Therapeutics, Erasca, and Science 37, showing their active role in company formation, launch, and fundraising efforts. LifeSci Venture Partners invests with an approximate range of $23,320,000, aiming to drive value creation and accelerate business plans for their investments.